Expression of hypoxia-inducible factor 1α and cathepsin D in pituitary adenomas

By Yoshida Daizo   Kim Kyongsong   Yamazaki Michio   Teramoto Akira  

Endocrine Pathology, Vol. 16, Iss. 2, 2005-06 ,pp. : 123-131

Humana Press, Inc

Access to resources Recommend Favorite

Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas

By Chang Edward   Sughrue Michael   Zada Gabriel   Wilson Charles   Blevins Lewis   Kunwar Sandeep  

Pituitary, Vol. 13, Iss. 3, 2010-09 ,pp. : 223-229

Springer Publishing Company

Access to resources Recommend Favorite

Cell cycle regulatory proteins p27^kip1, cyclins D1 and E and proliferative activity in oncocytic (Hürthle cell) lesions of the thyroid

By Maynes Lincoln   Hutzler Michael   Patwardhan Nilima   Wang Songtao   Khan Ashraf  

Endocrine Pathology, Vol. 11, Iss. 4, 2000-12 ,pp. : 331-340

Humana Press, Inc

Access to resources Recommend Favorite

MGMT Immunoexpression in Silent Subtype 3 Pituitary Adenomas: Possible Therapeutic Implications

By Fealey Michael   Scheithauer Bernd   Horvath Eva   Erickson Dana   Kovacs Kalman   McLendon Roger   Lloyd Ricardo  

Endocrine Pathology, Vol. 21, Iss. 3, 2010-09 ,pp. : 161-165

Humana Press, Inc

Access to resources Recommend Favorite

The clinical significance of MIB-1 labeling index in pituitary adenomas

By Chacko Geeta  

Pituitary, Vol. 13, Iss. 4, 2010-12 ,pp. : 337-344

Springer Publishing Company

Access to resources Recommend Favorite